What do our clients think about feline chronic lower airway disease management?
An online survey was distributed worldwide to cat owners caring for cats with a chronic cough. Only cats reported to have feline lower airway disease (FLAD) were included.
A total of 153 complete responses were analyzed.
Glucocorticoids and bronchodilators were the predominantly prescribed therapeutics for 140/153 (92%) and 80/153 (52%) of FLAD cats, respectively.
Oral and inhalant administration routes were reported most commonly: glucocorticoids (64% oral and 75% inhalant) and bronchodilators (21% oral and 88% inhalant).
Almost half (43%) of owners reported adverse effects secondary to glucocorticoid administration, the most frequent being polyphagia (26%) and polydipsia (21%).
Only 10% of owners reported bronchodilator-associated side effects, with restlessness (9%) being the most common.
Difficulties giving glucocorticoid or bronchodilator tablets orally were reported for 33% and 71% of owners, respectively.
Glucocorticoid or bronchodilator inhalant therapies were difficult to administer for 28% and 31% of owners, respectively.
Frequency and severity of coughing were significantly lower after at least 2 months of treatment.
Read more by clicking on the article below: